Frontlight ResearchEarly access
Taking peopleNo phase
SiREX-Stent for the Treatment of SymptOmatic Lateral VEnous Sinus Stenosis
Key facts
- Who runs it
- Acandis GmbH
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 78 people, planned
- Started
- Sept 2025
- Expected to end
- Jan 2029
- Type of study
- Interventional
- Treatments tested
- Sinus Stenting
- Record updated
- 4 September 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- • Patient ≥ 18 years old; Disabling pulsatile tinnitus lasting for more than three months; Venous type: pulsatile tinnitus is interrupted by ipsilateral jugular vein compression; Lateral sinus stenosis visible on venous MRA or venous angio CT; Exclusion of other cause (excepted dehiscence of the lateral sinus related to the stenosis) of PT on MRI and on the temporal bone CT; Stenosis located on a dominant or codominant lateral sinus; Stenosis associated with a venous gradient of at least 3 mm Hg under general anesthesia (GA) in the absence of sinus dehiscence, or 2 mm Hg under GA if there is sinus dehiscence in a mastoid cell; Patients asking for the treatment of her/his pulsatile tinnitus; Patients accepting to receive the SiREX® Stent (instead of a carotid stent); Written informed consent
Who cannot take part
- Any contraindication for treatment according to Instructions for Use:; Patients in whom the size of the venous vessel section to be treated does not lie within the range indicated for the stent; Patients for whom angiography shows that the anatomic morphology is not suitable for endovascular treatment due to severe vessel tortuosity or stenosis.Patients who were not pre-treated with antiplatelet agents prior to the procedure; Patients in whom treatment with antiplatelet agents and/or anticoagulants is contraindicated; Patients with an acute subarachnoid haemorrhage; Patients with an active bacterial infection; Patients who are hypersensitive to nickel-titanium
- Known, severe comorbidities, which will likely influence carrying out of the follow-up visits (cancer, alcohol/drug abuse or dementia)
- Non-pulsatile tinnitus or pulsatile tinnitus unrelated to lateral sinus stenosis
- Stenosis with gradient < 2 mm Hg in the absence of associated lateral sinus dehiscence
- Pregnant or breastfeeding woman
- Subject is participating in another clinical study
- Patients with a life-threatening event in the last 6 months
- Patients with a life expectancy under 12 months
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of the study is to assess the efficacy, safety and the clinical benefit of the SiREX stent for the treatment of disabling pulsatile tinnitus due to stenosis of lateral sinus.
Read full original descriptionShow less
The study will enrol patients suffering from pulsatile tinnitus related to a lateral sinus stenosis lasting more than three months, and who want to be treated with lateral sinus stenting
The group in the trial
- InterventionOther group
Novel medical device
Treatment: Sinus Stenting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 4 September 2025